Form EFFECT Damora Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 12, 2026 |
| Accession Number: | 0001193125-26-342562 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New White Paper from Secretary David J. Shulkin, MD, Outlines Strategy to Prevent 10,000 Veteran Hip Fractures a Year
- Finfare Garners “Alternative Cat Treat of the Year” Award In 2026 Pet Innovation Awards
- Studio City International Holdings Limited Announces Unaudited Second Quarter 2026 Earnings
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
